Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cilengitide in combination with temozolomide and radiotherapy for newly diagnosed glioblastoma with MGMT promoter methylation. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)
• cilengitide (cilengitide)

Snippet

Sponsor: EMD Serono | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2014-11-04